Carbapenem-resistant Enterobacteriaceae Infection
📧 Sign up to get email alerts when something new happens for Carbapenem-resistant Enterobacteriaceae Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: FMT for the Decolonization of Carbapenem-resistant Enterobacteriaceae [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating fecal microbiota transplantation to decolonize patients carrying carbapenem-resistant Enterobacteri…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: Risk Factors for Colonization or Infection With Carbapenem-Resistant Enterobacteriaceae in Children
A pediatric study sponsored by Children's Hospital of Fudan University is investigating risk factors for colonization or infection with carb…
-
CLINICAL_TRIALS research · 2025-09-08Clinical Trial Update: Microbiological and Clinical Characteristics of Severe Infections Caused by Carbapenem-Resistant Enterobacterales
This ClinicalTrials.gov entry outlines a study investigating microbiological and clinical characteristics of severe infections caused by car…
-
CLINICAL_TRIALS research · 2025-07-25Clinical Trial Update: Different Methods of Aerosolized Polymyxin B Inhalation for Treating Carbapenem-Resistant Gram-Negative Bacterial Pneumonia.
A clinical trial is evaluating different methods of inhaled aerosolized polymyxin B to treat pneumonia caused by carbapenem-resistant gram-n…
-
CLINICAL_TRIALS research · 2025-06-24Clinical Trial Update: Interventions to Decrease CRE Colonization and Transmission Between Hospitals, Households, Communities and Domesticated Animals [NA]
This clinical trial aims to test interventions to reduce carbapenem-resistant Enterobacteriaceae (CRE) colonization and transmission across …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: The Effect of Fecal Microbiota Transplantation on the Decolonization of Multidrug-resistant Organisms
A completed clinical trial evaluated fecal microbiota transplantation as a strategy to decolonize patients carrying multidrug-resistant orga…
-
CLINICAL_TRIALS research · 2025-06-19Clinical Trial Update: Efficacy and Safety of FMT for the Decolonization of MDROs in the Intestinal Tract [NA]
A clinical trial evaluating the efficacy and safety of fecal microbiota transplantation to decolonize multi-drug resistant organisms, specif…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Community-associated Highly-Resistant Enterobacterales
A UNC-Chapel Hill sponsor completed a clinical trial investigating community-associated highly-resistant Enterobacterales infections.
-
CLINICAL_TRIALS research · 2025-05-18Clinical Trial Update: Efficacy and Safety of Colistimethate Sodium for Injection in The Treatment of Carbapenem-Resistant Enterobacteriaceae Infection [NA]
Clinical trial evaluating the efficacy and safety of colistimethate sodium for injection in treating Carbapenem-Resistant Enterobacteriaceae…
-
CLINICAL_TRIALS trial_result · 2025-04-09Clinical Trial Update: A Novel Approach to Antimicrobial Resistance: Machine Learning Predictions for Carbapenem-Resistant Klebsiella in ICUs
Completed clinical trial assessing machine learning-based predictions for Carbapenem-Resistant Enterobacteriaceae infections in intensive ca…
-
CLINICAL_TRIALS research · 2025-03-12Clinical Trial Update: FMT to Eradicate Intestinal Colonization by Carbapenem-resistant Enterobacteriaceae [Phase 1, Phase 2]
This update covers a Phase 1/2 clinical trial evaluating fecal microbiota transplantation to eradicate intestinal colonization by carbapenem…
-
CLINICAL_TRIALS withdrawal · 2024-09-04Clinical Trial Update: Imipenem/Cilastatin/Relebactam (IMI/REL) in Treatment of CRE Infections [Phase 4]
A Phase 4 trial evaluating Imipenem/Cilastatin/Relebactam for carbapenem-resistant Enterobacteriaceae infections has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2024-06-14Clinical Trial Update: Ceftazidime-Avibactam Use in Critically Ill Patients With Carbapenem-Resistant Enterobacteriaceae Infections [Phase 3]
A Phase 3 trial evaluating ceftazidime-avibactam for carbapenem-resistant Enterobacteriaceae infections has been terminated.
-
CLINICAL_TRIALS research · 2024-04-30Clinical Trial Update: Epidemiological Features of Emergent Highly Resistant Bacteria in Tunisian Intensive Care Units
A clinical trial in Tunisian intensive care units is studying epidemiological features of emergent highly resistant bacteria, with recruitme…
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: EaRly impAct theraPy With Ceftazidime-avibactam Via rapID Diagnostics [Phase 4]
Phase 4 clinical trial evaluating rapid diagnostic-guided use of ceftazidime-avibactam for bloodstream infections and ventilator-associated …
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: Fecal Microbiota Transplantation for Carbapenem-resistant Enterobacteriaceae [Phase 2, Phase 3]
Clinical trial update on fecal microbiota transplantation for Carbapenem-resistant Enterobacteriaceae infection (phase 2/3), with completed …
-
CLINICAL_TRIALS trial_result · 2022-10-26Clinical Trial Update: Fecal Microbiota Transplantation for Carbapenem Resistant Enterobacteriaceae [Phase 2, Phase 3]
Clinical trial update on fecal microbiota transplantation for Carbapenem-Resistant Enterobacteriaceae infection, covering Phase 2 and Phase …
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Best Available Therapy With or Without Meropenem for Bloodstream Infections by Enterobacterales With High Level of Resistance to Carbapenems [Phase 2, Phase 3]
Phase 2/3 trial evaluating best available therapy with or without meropenem for bloodstream infections caused by carbapenem-resistant Entero…
-
CLINICAL_TRIALS trial_result · 2021-02-09Clinical Trial Update: Oral Capsule Faecal Microbiota Transplantation for CPE Decolonization [Phase 2, Phase 3]
Clinical trial update on an oral capsule fecal microbiota transplantation approach for decolonization of carbapenem-resistant Enterobacteria…
-
CLINICAL_TRIALS research · 2020-01-27Clinical Trial Update: Fecal Microbiota Transplantation for Eradication of CRE [Phase 1, Phase 2]
Clinical trial update on fecal microbiota transplantation to eradicate carbapenem-resistant Enterobacteriaceae (CRE) in Phase 1/2 completed.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: Carbapenem-resistant Enterobacteriaceae: Prevalence, Risk Factors and Impact of the Use of the Phenotypic Algorithm for the Detection of Carbapenemases
A completed clinical trial assessing the prevalence and risk factors for carbapenem-resistant Enterobacteriaceae. It also evaluated the impa…
-
CLINICAL_TRIALS research · 2016-06-20Clinical Trial Update: Prevalence of Enterobacteria With Decreased Susceptibility to Carbapenems in Eastern Inter- Region
A clinical trial update from CHU de Reims describes the prevalence of carbapenem-nonsusceptible Enterobacteriaceae in the Eastern Inter-Regi…